US2014349301A1PendingUtilityA1

Methods for Normalizing and for Identifying Small Nucleic Acids

Assignee: APPLIED BIOSYSTEMS LLCPriority: Mar 29, 2005Filed: Jun 2, 2014Published: Nov 27, 2014
Est. expiryMar 29, 2025(expired)· nominal 20-yr term from priority
C12Q 1/6855C12Q 1/6851
69
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present teachings are generally directed to methods for normalizing at least one species of small nucleic acid that is present in a population of small nucleic acid species, wherein the relative concentration of at least one small nucleic acid species is substantially greater than the relative concentration of at least one other small nucleic acid species in the population. At least one small nucleic acid species is normalized using a multiplicity of primers comprising degenerate sequences. In some embodiments, a small nucleic acid species is identified by inserting at least part of an extension product from a normalized population into a vector and subsequently sequencing the insert. In some embodiments, a small nucleic acid species is identified by determining the sequence of at least part of an extension product.

Claims

exact text as granted — not AI-modified
1 . A method for normalizing a population of different small nucleic acid species of varying abundance comprising,
 ligating adapters to at least one end of at least some of the nucleic acids in the population to form a multiplicity of different adapter-modified molecules; and   amplifying at least some of the different adapter-modified molecules using a multiplicity of primers, wherein at least some of the primers comprise a degenerate sequence located at the 3′-end of the primer to generate a normalized population.   
     
     
         2 . (canceled) 
     
     
         3 . The method of  claim 1 , wherein the generating a normalized population comprises employing a formulated relative concentration of primers comprising a multiplicity of primer species each comprising different degenerate sequences at their respective 3′-ends and a corresponding universal primer species, wherein the concentration of the universal primer species is at least ten times greater than the concentration of any one of the primer species comprising a degenerate sequence, and wherein the concentration of the universal primer is greater than the total concentration of the multiplicity of primers comprising different degenerate sequences. 
     
     
         4 . The method of  claim 1 , wherein the adapters comprise a 3′ adapter comprising a first primer-binding site, a 5′ adapter comprising a second primer-binding site, or a 3′ adapter comprising a first primer-binding site and a 5′ adapter comprising a second primer-binding site. 
     
     
         5 . The method of  claim 4 , wherein the 3′ adapter, the 5′ adapter, or the 3′ adapter and the 5′ adapter further comprise a restriction enzyme cleavage site. 
     
     
         6 . The method of  claim 4 , wherein the 5′ adapter, the 3′ adapter, or the 5′ adapter and the 3′ adapter comprise deoxyribonucleotides and ribonucleotides, and wherein at least the terminal nucleotide on the 3′-end of the 5′ adapter comprises a ribonucleotide, at least the terminal nucleotide on the 5′-end of the 3′ adapter comprises a ribonucleotide, or at least the terminal nucleotide on the 3′-end of the 5′ adapter comprises a ribonucleotide and at least the terminal nucleotide on the 5′-end of the 3′ adapter comprises a ribonucleotide. 
     
     
         7 . The method of  claim 6 , wherein at least the three terminal nucleotides on the 3′-end of the 5′ adapter comprise ribonucleotides, at least the three terminal nucleotides on the 5′-end of the 3′ adapter comprise ribonucleotides, or at least the three terminal nucleotides on the 3′-end of the 5′ adapter and at least the three terminal nucleotides on the 5′-end of the 3′ adapter comprise ribonucleotides. 
     
     
         8 . The method of  claim 1 , wherein the population of different small nucleic acids comprises at least two different noncoding RNAs. 
     
     
         9 . (canceled) 
     
     
         10 . The method of  claim 1 , further comprising degrading a small nucleic acid. 
     
     
         11 . (canceled) 
     
     
         12 . The method of  claim 1 , wherein at least one of the degenerate sequences comprises one, two, three, four, five, or six nucleotides. 
     
     
         13 . A method for identifying a species of small nucleic acid in a population of different small nucleic acid species of varying abundance comprising,
 ligating adapters to at least one end of at least some of the small nucleic acids in the population to form a multiplicity of different adapter-modified molecules;   amplifying at least some of the multiplicity of different adapter-modified molecules with a multiplicity of primers, wherein at least some of the primers comprise a degenerate sequence located at the 3′-end of the primer to generate a normalized population;   determining the nucleotide sequence of a normalized nucleic acid; and   identifying the corresponding small nucleic acid species.   
     
     
         14 . (canceled) 
     
     
         15 . The method of  claim 13 , wherein the generating a normalized population comprises employing a formulated relative concentration of primers comprising a multiplicity of primer species each comprising different degenerate sequences at their respective 3′-ends and a corresponding universal primer species, wherein the concentration of the universal primer species is at least ten times greater than the concentration of any one of the primer species comprising a degenerate sequence, and wherein the concentration of the universal primer is greater than the total concentration of the multiplicity of primers comprising different degenerate sequences. 
     
     
         16 . The method of  claim 13 , wherein the adapters comprise a 3′ adapter comprising a first primer-binding site, a 5′ adapter comprising a second primer-binding site, or a 3′ adapter comprising a first primer-binding site and a 5′ adapter comprising a second primer-binding site. 
     
     
         17 . The method of  claim 16 , wherein the 3′ adapter, the 5′ adapter, or the 3′ adapter and the 5′ adapter further comprise a restriction enzyme cleavage site. 
     
     
         18 . The method of  claim 16 , wherein the 5′ adapter, the 3′ adapter, or the 5′ adapter and the 3′ adapter comprise deoxyribonucleotides and ribonucleotides, and wherein at least the terminal nucleotide on the 3′-end of the 5′ adapter comprises a ribonucleotide, at least the terminal nucleotide on the 5′-end of the 3′ adapter comprises a ribonucleotide, or at least the terminal nucleotide on the 3′-end of the 5′ adapter comprises a ribonucleotide and at least the terminal nucleotide on the 5′-end of the 3′ adapter comprises a ribonucleotide. 
     
     
         19 . The method of  claim 18 , wherein at least the three terminal nucleotides on the 3′-end of the 5′ adapter comprise ribonucleotides, at least the three terminal nucleotides on the 5′-end of the 3′ adapter comprise ribonucleotides, or at least the three terminal nucleotides on the 3′-end of the 5′ adapter and at least the three terminal nucleotides on the 5′-end of the 3′ adapter comprise ribonucleotides. 
     
     
         20 . The method of  claim 13 , further comprising degrading a small nucleic acid. 
     
     
         21 . The method of  claim 13 , wherein at least one of the degenerate sequences comprises one, two, three, four, five, or six nucleotides. 
     
     
         22 . The method of  claim 13 , wherein the determining the nucleotide sequence comprises:
 inserting at least a portion of a normalized nucleic acid into a vector;   amplifying the vector comprising the insert in a host cell; and   sequencing at least part of the insert of the amplified vector or its complement.   
     
     
         23 . (canceled) 
     
     
         24 . The method of  claim 13 , wherein the determining the nucleotide sequence comprises sequencing at least part of a normalized nucleic acid or its complement. 
     
     
         25 . (canceled) 
     
     
         26 . A method for identifying a miRNA species in a population of different small nucleic acid species of varying abundance comprising,
 ligating a 3′ adapter and a 5′ adapter to at least one end of at least some of the small nucleic acids in the population to form a multiplicity of double different adapter-modified molecules, wherein the adapters comprise a 3′ adapter comprising a first primer-binding site and a restriction enzyme cleavage site, a 5′ adapter comprising a second primer-binding site and a restriction enzyme cleavage site, wherein the 5′ adapter and the 3′ adapter comprise deoxyribonucleotides and ribonucleotides, and wherein at least the terminal nucleotide on the 3′-end of the 5′ adapter comprises a ribonucleotide and at least the terminal nucleotide on the 5′-end of the 3′ adapter comprises a ribonucleotide;   amplifying at least some of the multiplicity of different double adapter-modified molecules with a formulated relative concentration of primers to generate a normalized population, wherein the formulated relative concentration of primers comprises a multiplicity of primer species each comprising different degenerate sequences at their respective 3′-ends and a corresponding universal primer species, wherein at least one of the degenerate sequences comprises one, two, three, four, five, or six nucleotides, wherein the concentration of the universal primer species is at least ten times greater than the concentration of any one of the primer species comprising a degenerate sequence, and wherein the concentration of the universal primer is greater than the total concentration of the multiplicity of primers comprising different degenerate sequences, and wherein the amplifying comprises a polymerase chain reaction;   determining the nucleotide sequence of a normalized nucleic acid comprising: (a) inserting at least a portion of a normalized nucleic acid into a vector; (b) amplifying the vector comprising the insert in a host cell; and (c) sequencing at least part of the insert of the amplified vector or its complement; and   identifying the corresponding miRNA species.

Join the waitlist — get patent alerts

Track US2014349301A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.